[¦å¿}] ¬õÄT¥NÁ²£ª« monascin Âǥѧí¨î PPAR- ÁC»Ä¤Æ§ïµ½ TNF- »¤¾É¤§ C2C12¦Ù¦×²ÓM¯Ø®q¯À§Ü©Ê
The Monascus Metabolite Monascin Against TNF--Induced Insulin Resistance via Suppressing PPAR- Phosphorylation in C2C12 Myotubes
Food and Chemical Toxicology (2011) 49: 2609-2617.
¦Ù¦×²Õ´ªººC©Êµoª¢·|¾ÉP¯Ø®q¯À§Ü©Ê©M 2 «¬¿}§¿¯f¡C¬ã¨sÅã¥Ü¡A¹L®ñ¤Æª«–¡Åé¼W´Þª«±Ò°Ê¨üÅé (Peroxisome proliferator - activated receptor, PPAR) ªº°tÅé·|¬¡¤ÆÁC¯×ñQ¦Ù¾J 3 ¿E–¡ (phosphatidylinositol 3-kinase, PI3K)/Akt ³~®|¡APPAR ªº°tÅé¥]¬AÄÝ©ó–ÊÐüÖJ¤Gà¬Ãþ (thiazolidinedione, TZD) ªº–²®æ¦Cଠ(pioglitazone)¡C³Ìªñªº¬ã¨sµo²{¬õÄTªº¥NÁ²£ª« monascin (MS) ¨ã§Üµoª¢¬¡©Ê¡C¦]¦¹¡A¥»¬ã¨s¥H¸~½FÃa¦º¦]¤l-£\ (TNF-£\; 20 ng/mL) »¤¾É C2C12 ¦Ù¦×²ÓM²£¥Í¯Ø®q¯À§Ü©Êªº¼Ò¦¡¡A±´°Q MS ´î»´¯Ø®q¯À§Ü©Êªº¾÷¨î¡Cµ²ªGÅã¥Ü¡AMS §í¨î p-JNK ªº¬¡©Ê¨Ã¥Bªý¤î PPAR-£^ ÁC»Ä¤Æ¡A¦]¦¹¾ÉP PPAR-£^ ¬¡¤Æ©M PI3K/Akt ³~®|¡A³Ì«á C2C12 ²ÓMÄá¨ú 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose (2- NBDG) ¼W¥[¡C¦¹¥~¡A¦b PPAR-£^ «ú§Ü¾¯ (GW9662) ªº¹êÅç¡A§Ú̶i¤@¨BÃÒ¹ê¡AMS ¥i¯à§@¬° PPAR- £^ «P®Ä¾¯¦]¦Ó´£°ª¯Ø®q¯Àªº±Ó·P©Ê¡C²³æ¦a»¡¡AMS ªº§@¥Î¦ü–²®æ¦CଡAéw PPAR- £^ ªºµ²ºc©M´î¤Ö PPAR- £^ ÁC»Ä¤Æ¡A¦]¦Ó§ïµ½¯Ø®q¯À§Ü©Ê¡C
|